Literature DB >> 16036753

Expression of C-reactive protein in human lung epithelial cells and upregulation by cytokines and carbon particles.

Lindsay Ramage1, Lorna Proudfoot, Keith Guy.   

Abstract

C-reactive protein (CRP) is the prototypic human acute-phase protein and is found at increased levels in the blood during episodes of inflammation. CRP was generally thought to be produced only by hepatocytes; however, several studies have shown extrahepatic synthesis of CRP. A previous study showed that PM10 and ultrafine carbon black (ufCB) were able to induce CRP expression in A549 cells. This study aims to examine the factors that lead to the production of CRP in A549 cells. A549 human lung epithelial cells were treated with cytokines (interleukin 6, tumor necrosis factor alpha, interferon gamma, or interleukin 1beta) or carbon particles (CB and ufCB) for 18 h. It was found that CRP could be expressed within the cells and that CRP was secreted from the cells particularly with tumor necrosis factor alpha, CB and ufCB treatments. It was also found that this expression of CRP with CB and ufCB treatments was dependent on nuclear factor kappa B (NFkappaB). The expression of CRP in A549 cells may indicate an important role for CRP expression and secretion from lung epithelial cells in response to inflammatory stimuli.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16036753     DOI: 10.1080/08958370490464599

Source DB:  PubMed          Journal:  Inhal Toxicol        ISSN: 0895-8378            Impact factor:   2.724


  19 in total

1.  C-reactive protein in vulnerable coronary plaques.

Authors:  Silja Norja; Lauri Nuutila; Pekka J Karhunen; Sirkka Goebeler
Journal:  J Clin Pathol       Date:  2006-06-21       Impact factor: 3.411

2.  Quantum dots trigger immunomodulation of the NFκB pathway in human skin cells.

Authors:  Amelia A Romoser; Patricia L Chen; J Michael Berg; Christopher Seabury; Ivan Ivanov; Michael F Criscitiello; Christie M Sayes
Journal:  Mol Immunol       Date:  2011-04-09       Impact factor: 4.407

Review 3.  Effect of particulate matter air pollution on C-reactive protein: a review of epidemiologic studies.

Authors:  Yanli Li; Kate Rittenhouse-Olson; William L Scheider; Lina Mu
Journal:  Rev Environ Health       Date:  2012       Impact factor: 3.458

Review 4.  Regulation of C-reactive protein conformation in inflammation.

Authors:  ZhenYu Yao; Yanmin Zhang; HaiBin Wu
Journal:  Inflamm Res       Date:  2019-07-16       Impact factor: 4.575

5.  Causal Inference Analysis for Poorly Soluble Low Toxicity Particles, Lung Function, and Malignancy.

Authors:  Philip Harber
Journal:  Front Public Health       Date:  2022-07-05

6.  CRP gene variation and risk of community-acquired pneumonia.

Authors:  Kenneth J Mukamal; Jennifer K Pai; Ellen S O'Meara; Russell P Tracy; Bruce M Psaty; Lewis H Kuller; Anne B Newman; Sachin Yende; Gary C Curhan; David S Siscovick; Eric B Rimm
Journal:  Respirology       Date:  2009-11-23       Impact factor: 6.424

7.  C-reactive protein and serum amyloid a overexpression in lung tissues of chronic obstructive pulmonary disease patients: a case-control study.

Authors:  Jose Luis López-Campos; Carmen Calero; Belén Rojano; Marta López-Porras; Javier Sáenz-Coronilla; Ana I Blanco; Verónica Sánchez-López; Daniela Tobar; Ana Montes-Worboys; Elena Arellano
Journal:  Int J Med Sci       Date:  2013-06-08       Impact factor: 3.738

Review 8.  Targeting C-Reactive Protein in Inflammatory Disease by Preventing Conformational Changes.

Authors:  J R Thiele; J Zeller; H Bannasch; G B Stark; K Peter; S U Eisenhardt
Journal:  Mediators Inflamm       Date:  2015-05-18       Impact factor: 4.711

9.  Local C-reactive protein expression in obliterative lesions and the bronchial wall in posttransplant obliterative bronchiolitis.

Authors:  Outi E Päiväniemi; Paula K Maasilta; Tiina L S Vainikka; Hanni S Alho; Pekka J Karhunen; Ulla-Stina Salminen
Journal:  Mediators Inflamm       Date:  2009-05-26       Impact factor: 4.711

10.  IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study.

Authors:  Dilyara G Yanbaeva; Mieke A Dentener; Martijn A Spruit; Jeanine J Houwing-Duistermaat; Daniel Kotz; Valéria Lima Passos; Emiel F M Wouters
Journal:  BMC Med Genet       Date:  2009-03-09       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.